It had been shown that etoposide treatment to patients can induce acute myeloid leukemia (t-AML) (16), which is attributed to TOP2B-, but not TOP2A-mediated DNA damage that disrupts the mixed lineage leukemia (MLL) gene and MLL associated genes in benign bone marrow cells (16). Here, KMT2A is linked to acute myeloid leukemia.